Human Papillomavirus Vaccine
Human papillomavirus vaccine immunogenic and antiangiogenic
Published in Cancer Weekly, July 25th, 2006
According to recently published research from the People's Republic of China, "Calreticulin (CRT) has been reported to have an effect of upregulating MHC class I presentation as well as inhibiting angiogenesis in vitro and in vivo.
"Combination of dual mechanisms of enhanced immunogenicity of human papillomavirus (HPV) 6bE7 antigen and antiangiogenesis may be introduced in the strategy of vaccines against condyloma acuminatum (CA) resulting from HPV infection."
"Therefore," wrote the authors, "we constructed DNA vaccines by employing different lengths of CRT...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-07-25)
More Articles from Cancer Weekly
- Gynecologic Cancer
Psychoeducational intervention increased compliance with vaginal dilation - Non-Hodgkin Lymphoma
Non-Hodgkin lymphoma risk linked to cytokine polymorphisms in the Tb1/Th2 pathway - Oral Cancer
Oral cancer risk reduced with fruit and vegetable consumption - Prostate Cancer
Effect on prostate cancer treatment with IMRT by setup errors and organ motion assessed - Tumorigenesis
Acid-mediated tumor invasion model implicated altered glucose metabolism in cancer pathology - AIDS-Related Lymphoma
HIV score, IPI score and HAART affects survival in AIDS-related non-Hodgkin lymphoma - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
